---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-002897"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2025-04-22T23:59:59+00:00"
generated_at: "2026-05-23T09:55:38.904251+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# VolitionRx enters up to $7.5M at-the-market stock offering agreement with JonesTrading

## Summary
- New 'Capital on Demand' sales agreement with JonesTrading allows sale of up to $7.5M common stock via ATM.
- Sales agent commission 3% of gross proceeds; company not obligated to sell any shares.
- Replaces prior $25M ATM program with Jefferies, terminated effective April 20, 2025.
- Proceeds intended for R&D, product development, clinical studies, commercialization, working capital, and potential acquisitions.

## SEC filing metadata
- accession: 0001477932-25-002897
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2025-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793225002897/0001477932-25-002897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793225002897/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-002897
- JSON: https://secwatch.observer/filing/0001477932-25-002897.json
- Plain text: https://secwatch.observer/filing/0001477932-25-002897.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.